Skip to main content
. 2024 Jul 18;74:102733. doi: 10.1016/j.eclinm.2024.102733

Fig. 3.

Fig. 3

Mean (SE) haemolytic markers from baseline (BL) to week 79, then last on-treatment visit with available assessment (LV). a) lactate dehydrogenase [LDH], b) reticulocyte count, c) haptoglobin. Only non-missing values are considered. LV is the last on-treatment visit with available assessment. PBO, placebo. SE, standard error. SUT, sutimlimab.